Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours Β· Estimated delivery Sep 23 - Sep 28
In addition, one episode of severe hypoglycemia requiring intravenous glucose was reported in a WEGOVY-treated patient versus none in placebo-treated patients
Psychological factors also warrant consideration
However, the drugs manufacturer, Novo Nordisk, does not report it as a side effect
Medication is only prescribed when clinically appropriate following provider evaluation
It helps neutralize free radicals and reactive oxygen species, which are harmful molecules that damage cells and lead to various health problems
Additional Wegovy-specific risks that require monitoring include pancreatitis (presenting as severe abdominal pain), cholelithiasis (gallstones), and potential worsening of diabetic retinopathy in patients with diabetes
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
